Products & Services · Alliance revenues

Total Alliance revenues — Alliance revenues

Pfizer Total Alliance revenues — Alliance revenues increased by 10.7% to $2.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $2.11B to $2.34B. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026

How to read this metric

An increase suggests successful commercial execution of partnered assets or the expansion of collaborative drug portfolios, while a decrease may indicate maturing partnerships or shifts in strategic alliance focus.

Detailed definition

This metric represents the portion of total revenue generated through collaborative arrangements and strategic partnersh...

Peer comparison

Similar to 'Collaboration Revenue' or 'Co-promotion Income' reported by large-cap biopharma peers, which often fluctuates based on the lifecycle stage of partnered drugs.

Metric ID: pfe_segment_total_alliance_revenues_alliance_revenues

Historical Data

12 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '25Q1 '26
Value$1.91B$1.91B$1.91B$2.31B$2.32B$1.69B$2.22B$2.06B$1.97B$1.65B$2.11B$2.34B
QoQ Change+0.0%+0.0%+21.0%+0.1%-27.1%+31.3%-7.1%-4.5%-16.4%+28.4%+10.7%
YoY Change+21.1%-11.7%+15.9%-11.0%-15.1%-2.6%+10.7%
Range$1.65B$2.34B
CAGR+7.6%
Avg YoY Growth+1.0%
Median YoY Growth-2.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Pfizer's total alliance revenues — alliance revenues?
Pfizer (PFE) reported total alliance revenues — alliance revenues of $2.34B in Q1 2026.
How has Pfizer's total alliance revenues — alliance revenues changed year-over-year?
Pfizer's total alliance revenues — alliance revenues increased by 10.7% year-over-year, from $2.11B to $2.34B.
What does total alliance revenues — alliance revenues mean?
Revenue earned through collaborative partnerships and profit-sharing agreements with other healthcare companies.